« Return to News | Technology Solutions

ARX, InnovoCommerce partner

Tuesday, March 29, 2011 11:37 AM

ARX, a provider of digital signature solutions, has partnered with InnovoCommerce, an independent software vendor.

InnovoCommerce helps solve complex governance, risk management and compliance business challenges using the Microsoft technology platform with a core focus on Microsoft SharePoint. InnovoCommerce is the developer of innovoPOINT, a clinical and investigator portal solution.

InnovoCommerce now offers the CoSign digital signature solution as part of its two core offerings, the innovoPOINT Clinical investigator portal, and innovoPOINT DM, a document management solution for life science organizations. CoSign can be used in FDA Title 21 CFR part 11 compliant processes by pharmaceutical and biotechnology companies for signing SOPs, quality and compliance documentation, research and development documentation, corporate compliance documents, and more. InnovoPOINT Clinical customers can also use CoSign for obtaining signatures from external parties, such as clinical trial investigators.

CoSign is also being used within InnovoCommerce as part of the in-house innovoPOINT DM deployment. Employees use the integrated solution to digitally sign PDF files that have been converted from Word, including SOPs and quality documents. 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.